Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH)

Joseph Pidala1, Paul A Carpenter2,3, Lynn Onstad2

  • 1Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States of America.

Plos One
|May 16, 2024
PubMed

Insights

The Close Assessment and Testing for Chronic GVHD (CATCH) study aims to identify biomarkers for chronic graft-versus-host disease (GVHD) after transplantation. This research will improve understanding and management of this serious immune complication.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Biomarker Discovery

Background:

  • Chronic graft-versus-host disease (GVHD) is a significant complication following allogeneic hematopoietic cell transplantation.
  • It leads to substantial late morbidity and mortality in transplant recipients.

Purpose of the Study:

  • To prospectively identify clinical and biologic biomarkers for chronic GVHD onset.
  • To closely monitor patients pre- and post-transplant to capture GVHD development.
  • To facilitate collaboration for leveraging the CATCH study resource.

Main Methods:

  • Prospective, multi-center, longitudinal cohort study design.
  • Enrollment of patients before hematopoietic cell transplantation.
  • Collection of comprehensive data including clinical assessments, patient-reported outcomes, biospecimens (blood, saliva, etc.), laboratory tests, and medical records.
  • Data collection at baseline, every two months for one year, and ongoing chart review.

Main Results:

  • This report focuses on the study's rationale, design, and methods.
  • Detailed findings on biomarker identification and clinical outcomes will be reported as the study progresses.

Conclusions:

  • The CATCH study provides a robust framework for understanding chronic GVHD.
  • The study aims to improve early detection and management strategies for chronic GVHD.
  • Collaboration is encouraged to maximize the impact of this research resource.